MedMira Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MIR.V research report →
Price Chart
About the company
MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia Pacific region, and other international markets.
- CEO
- Hermes Chan
- IPO
- 1999
- Employees
- 52
- HQ
- Halifax, NS, CA
Get TickerSpark's AI analysis on MIR.V
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $42.10M
- P/E
- -13.64
- PEG
- -0.30
- P/S
- 113.62
- P/B
- -1.71
- EV/EBITDA
- -33.96
- Div Yield
- 0.00%
- Gross Margin
- -448.07%
- Op Margin
- -473.40%
- Net Margin
- -808.18%
- ROE
- 12.68%
- ROIC
- 24.72%
Latest fiscal year · YoY change
- Revenue
- $240.51K-41.7%
- Gross Profit
- $-990,255-537.2%
- Op Income
- $-3,589,747
- Net Income
- $-4,524,407-36.0%
- EPS
- $-0.01-35.4%
- OCF Growth
- -7.0%
- FCF Growth
- +14.3%
- 52W High
- $0.11
- 52W Low
- $0.05
- 50D MA
- $0.07
- 200D MA
- $0.07
- Beta
- 0.76
- RSI (14)
- 47
- Avg Volume
- 54.99K
No earnings-call transcripts are available for MIR.V yet.
- Free Float
- 29.9%
- Shares Outstanding
- 701.73M
- Float Shares
- 209.72M
Our MIR.V coverage
Recent articles, reports, and earnings notes.
No research on MIR.V yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MIR.V report →